Answer
As a precaution, it is preferable to avoid Vyepti (eptinezumab) during pregnancy because human pregnancy data are limited and eptinezumab may cross the placenta to the developing fetus.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked